Original Research

Published on 24 Sep 2024

Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b

in Pharmacology of Anti-Cancer Drugs

Albert Qin
Daoxiang Wu
Jason Liao
Shuping Xie
Haoqi Chen
Yucheng Gao
Jie Cui
Xia Su
Narihisa Miyachi
Toshiaki Sato

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1455979

669 views

Original Research

Accepted on 23 Sep 2024

Targeting Autophagy: Polydatin's Role in Inducing Cell Death in AML

in Pharmacology of Anti-Cancer Drugs

Ping Fu
Qing Luo
Chao Wang
Liping Chen
Chang Dong
Ke Yang
Guang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1470217

Original Research

Published on 23 Sep 2024

Analysis of chromatin accessibility in peripheral blood mononuclear cells from patients with early-stage breast cancer

in Pharmacology of Anti-Cancer Drugs

Longjie Xia
Jiamin Lu
Yixuan Qin
Runchun Huang
Fanbiao Kong
Yu Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1465586

550 views

Review

Published on 20 Sep 2024

Advancing cancer therapy: new frontiers in targeting DNA damage response

in Pharmacology of Anti-Cancer Drugs

Jiekun Qian
Guoliang Liao
Maohui Chen
Ren-Wang Peng
Xin Yan
Jianting Du
Renjie Huang
Maojie Pan
Yuxing Lin
Xian Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1474337

1,332 views

Original Research

Published on 20 Sep 2024

Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system

in Pharmacology of Anti-Cancer Drugs

Qiong Jie
Yuanyuan Li
Li Jing
Jinjin Chen
Yang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424980

845 views
1 citation

Systematic Review

Published on 18 Sep 2024

Efficacy and safety of PARP inhibitor maintenance therapy for ovarian cancer: a meta-analysis and trial sequential analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Guojuan Sun
Yi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1460285

833 views

Original Research

Published on 17 Sep 2024

Extrachromosomal circular DNAs in prostate adenocarcinoma: global characterizations and a novel prediction model

in Pharmacology of Anti-Cancer Drugs

Qingliu He
Qingfu Su
Chengcheng Wei
Pu Zhang
Weihui Liu
Junyi Chen
Xiaoping Su
Wei Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464145

666 views

Original Research

Published on 16 Sep 2024

Integrated analyses reveal IDO1 as a prognostic biomarker coexpressed with PD-1 on tumor-associated macrophages in esophageal squamous cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Yaojun Peng
Lingxiong Wang
Juan Yang
Qiyan Wu
Xiaoxuan Sun
Jinying Zhang
Yanju Yu
Liping Zhang
Jie Gao
Qing Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466779

797 views

Opinion

Published on 16 Sep 2024

Cholesterol metabolism: a positive target to revoke the function of exhausted CAR-NK cells in tumor microenvironment

in Pharmacology of Anti-Cancer Drugs

Jingfeng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440869

510 views

Review

Published on 16 Sep 2024

Roles of small peptides encoded by non-coding RNAs in tumor invasion and migration

in Pharmacology of Anti-Cancer Drugs

Jie Liu
Xiyue Chang
Laeeqa Manji
Zhijie Xu
Wan’an Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1442196

502 views

Review

Published on 16 Sep 2024

HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future

in Pharmacology of Anti-Cancer Drugs

Luying Xu
Yuxin Xie
Qiheng Gou
Rui Cai
Rong Bao
Yucheng Huang
Ruisi Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1446414

1,238 views

Review

Published on 16 Sep 2024

A comprehensive review on the potential of coumarin and related derivatives as multi-target therapeutic agents in the management of gynecological cancers

in Pharmacology of Anti-Cancer Drugs

Gökçe Şeker Karatoprak
Berrak Dumlupınar
Engin Celep
Inci Kurt Celep
Esra Küpeli Akkol
Eduardo Sobarzo-Sánchez

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1423480

952 views
1 citation

Systematic Review

Published on 13 Sep 2024

Research trends on chemotherapy induced nausea and vomiting: a bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Chunhui Ning
Yunzi Yan
Yansong Wang
Rui Li
Wenjie Liu
Linjie Qiu
Lingyun Sun
Yufei Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369442

960 views

Original Research

Published on 12 Sep 2024

Research hotspots and trends of epigenetic therapy in oncology: a bibliometric analysis from 2004 to 2023

in Pharmacology of Anti-Cancer Drugs

Sisi Li
Xinrui Liang
Qing Shao
Guanwen Wang
Yuxin Huang
Ping Wen
Dongping Jiang
Xiaohua Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1465954

886 views

Systematic Review

Published on 12 Sep 2024

Mapping and visualization of global research progress on deubiquitinases in ovarian cancer: a bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Fang Qiu
Yuntong Li
Lile Zhou
Yingli Wu
Yunzhao Wu
Zhilei Fan
Yingying Wang
Dongjun Qin
Chaoqun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1445037

864 views

Brief Research Report

Published on 12 Sep 2024

Overcoming drug resistance of cancer cells by targeting the FGF1/FGFR1 axis with honokiol or FGF ligand trap

in Pharmacology of Anti-Cancer Drugs

Jakub Szymczyk
Martyna Sochacka
Martyna Biadun
Katarzyna Dominika Sluzalska
Danuta Witkowska
Malgorzata Zakrzewska

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1459820

487 views

Navigation group

Articles

Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b

Targeting Autophagy: Polydatin's Role in Inducing Cell Death in AML

Analysis of chromatin accessibility in peripheral blood mononuclear cells from patients with early-stage breast cancer

Advancing cancer therapy: new frontiers in targeting DNA damage response

Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system

Efficacy and safety of PARP inhibitor maintenance therapy for ovarian cancer: a meta-analysis and trial sequential analysis of randomized controlled trials

Extrachromosomal circular DNAs in prostate adenocarcinoma: global characterizations and a novel prediction model

Integrated analyses reveal IDO1 as a prognostic biomarker coexpressed with PD-1 on tumor-associated macrophages in esophageal squamous cell carcinoma

Cholesterol metabolism: a positive target to revoke the function of exhausted CAR-NK cells in tumor microenvironment

Roles of small peptides encoded by non-coding RNAs in tumor invasion and migration

HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future

A comprehensive review on the potential of coumarin and related derivatives as multi-target therapeutic agents in the management of gynecological cancers

Research trends on chemotherapy induced nausea and vomiting: a bibliometric analysis

Research hotspots and trends of epigenetic therapy in oncology: a bibliometric analysis from 2004 to 2023

Mapping and visualization of global research progress on deubiquitinases in ovarian cancer: a bibliometric analysis

Overcoming drug resistance of cancer cells by targeting the FGF1/FGFR1 axis with honokiol or FGF ligand trap